All Updates

Tonight the House is considering a long-overdue FY2022 funding bill that addresses critical aspects of cancer research, prevention and access to care.

The 2021-22 Wisconsin legislative session ended this week. This session was marked by important wins for cancer prevention and early detection, as well as battles against unwarranted efforts to create barriers to accessing care.

ACS CAN is joined by more than 65 organizations asking for colorectal screening to be included in the budget.

The Los Angeles City Arts, Parks, Health, Education and Neighborhoods Committee voted today to advance a draft ordinance that would end the sale of flavored tobacco products, including e-cigarettes and menthol cigarettes. The ordinance now moves to full council for consideration.

The Los Angeles City Arts, Parks, Health, Education and Neighborhoods Committee voted today to advance a draft ordinance that would end the sale of flavored tobacco products, including e-cigarettes and menthol cigarettes. The ordinance now moves to full council for consideration.

INDIANAPOLIS, IN. – Today, our elected officials worked to reduce the burden of cancer on Hoosier by passing House Bill 1238, which will eliminate cost sharing for all preventative colorectal cancer screenings, including follow-up colonoscopies after an abnormal stool-based test for most private insurance plans. “Colorectal cancer remains the second

Wednesday marks six months since the U.S. Food and Drug Administration (FDA) failed to meet its court-ordered deadline to rule on all e-cigarette and other new tobacco product manufacturers’ applications.

The Iowa House on Monday approved House File 2412, which would require radon testing and mitigation in Iowa schools. The Gail Orcutt School Radon Safety Bill (named after a beloved retired teacher who died of radon-induced lung cancer) now heads to the Senate.

The American Cancer Society Cancer Action Network (ACS CAN) has been provided nearly one million dollars in support from Amgen for a pilot program to test a trial eligibility screening intervention intended to increase and diversify patient enrollment in cancer clinical trials.